Proceedings of the 7th International Conference on Economy, Management, Law and Education (EMLE 2021)

Considerations on Regulatory Quality Control in Pharmaceutical Industry

Authors
Zihan Xu1, *
1King’s College London, London E149ZN, UK
*Corresponding author. Email: sarah010309@163.com
Corresponding Author
Zihan Xu
Available Online 17 March 2022.
DOI
10.2991/aebmr.k.220306.047How to use a DOI?
Keywords
Pharmaceutics; Quality system; GMP; ICH; Pharmacopeia
Abstract

With the development of pharmaceutical fields, the quality control of the pharmaceutical industry gets more and more attention. The aims of pharmaceutical industry are manufacturing high quality medicines, identifying the safety of products and assessing the efficacy of medicines. Pharmaceutical industry has to achieve the manufacturing standard which is regulated by the authorities. The industry or company requires to adhere the medicines principles such as Pharmacopoeia, Good manufacturing practice (GMP) or International Council on Harmonisation (ICH) and manufacturing medical products should follow the Standard Operation Procedure (SOP). In order to build a good medical quality supervision system, industry needs to control the monitoring of every step of medicines in production process from many different perspectives. Also, doing the sampling inspection for products to make sure the characterization of medicines could help to achieve the standard. Therefore, this paper will focus on the importance and advantages of regulatory control of medicines, research on the factors that affect the medicines quality in pharmaceutical industry and puts forward some effective ways to improve the quality of manufacturing.

Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

Volume Title
Proceedings of the 7th International Conference on Economy, Management, Law and Education (EMLE 2021)
Series
Advances in Economics, Business and Management Research
Publication Date
17 March 2022
ISBN
10.2991/aebmr.k.220306.047
ISSN
2352-5428
DOI
10.2991/aebmr.k.220306.047How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

TY  - CONF
AU  - Zihan Xu
PY  - 2022
DA  - 2022/03/17
TI  - Considerations on Regulatory Quality Control in Pharmaceutical Industry
BT  - Proceedings of the 7th International Conference on Economy, Management, Law and Education (EMLE 2021)
PB  - Atlantis Press
SP  - 324
EP  - 328
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220306.047
DO  - 10.2991/aebmr.k.220306.047
ID  - Xu2022
ER  -